{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:18:38Z","timestamp":1788866318651,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.eprac.2023.12.008","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:34:38Z","timestamp":1702575278000},"page":"218-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid Cancer"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6670-2254","authenticated-orcid":false,"given":"Matti L.","family":"Gild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shejil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia L.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sywak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venessa","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Schembri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick J.","family":"Clifton-Bligh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eprac.2023.12.008_bib1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.008_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.008_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/pr.117.015388","article-title":"International Union of Basic and Clinical Pharmacology. CV. Somatostatin receptors: structure, function, ligands, and new nomenclature","volume":"70","author":"Gunther","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.eprac.2023.12.008_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.008_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MNM.0000000000000240","article-title":"Comparison of \u2076\u2078Ga-DOTATATE PET-CT, 1\u2078F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma","volume":"36","author":"Ozkan","year":"2015","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.008_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00259-009-1204-z","article-title":"Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET\/CT in the detection of recurrent medullary thyroid carcinoma","volume":"37","author":"Conry","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.eprac.2023.12.008_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s12149-021-01627-2","article-title":"Evaluation of F-18 DOPA PET\/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET\/CT","volume":"35","author":"Asa","year":"2021","journal-title":"Ann Nucl Med"},{"issue":"12","key":"10.1016\/j.eprac.2023.12.008_bib8","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00259-017-3759-4","article-title":"Diagnostic utility of PET\/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff","volume":"44","author":"Romero-Lluch","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.eprac.2023.12.008_bib9","first-page":"2417","article-title":"Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma","volume":"83","author":"Mato","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.008_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12020-018-1706-1","article-title":"SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival","volume":"62","author":"de Vries","year":"2018","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.eprac.2023.12.008_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2265.2001.01175.x","article-title":"Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid","volume":"54","author":"Papotti","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.eprac.2023.12.008_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/apm.12584","article-title":"Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis","volume":"124","author":"Herac","year":"2016","journal-title":"APMIS"},{"issue":"9","key":"10.1016\/j.eprac.2023.12.008_bib13","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1210\/jc.2018-00193","article-title":"Comparison of 68Ga PET\/CT to other imaging studies in medullary thyroid cancer: superiority in detecting bone metastases","volume":"103","author":"Castroneves","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2023.12.008_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/PAS.0000000000001505","article-title":"A\u00a0proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (Ki-67 and mitotic count) and coagulative necrosis","volume":"44","author":"Fuchs","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.008_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.pathol.2017.10.024","article-title":"Immunohistochemical expression of somatostatin receptors SSTR2A and SSTR5 in 299 pituitary adenomas","volume":"50","author":"Fuchs","year":"2018","journal-title":"Pathology"},{"issue":"40","key":"10.1016\/j.eprac.2023.12.008_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001281","article-title":"Somatostatin receptor SSTR-2a expression is a stronger predictor for survival than Ki-67 in pancreatic neuroendocrine tumors","volume":"94","author":"Mehta","year":"2015","journal-title":"Med (Baltim)"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.008_bib18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.21.01329","article-title":"International Medullary Thyroid Carcinoma Grading System: a validated grading system for medullary thyroid carcinoma","volume":"40","author":"Xu","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.eprac.2023.12.008_bib19","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1158\/0008-5472.CAN-06-4605","article-title":"The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells","volume":"67","author":"Akeno-Stuart","year":"2007","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.008_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cen.13737","article-title":"Role of DOTATATE-PET\/CT in preoperative assessment of phaeochromocytoma and paragangliomas","volume":"89","author":"Gild","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.008_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14310\/horm.2002.1756","article-title":"Detection rate of somatostatin receptor PET in patients with recurrent medullary thyroid carcinoma: a systematic review and a meta-analysis","volume":"16","author":"Treglia","year":"2017","journal-title":"Hormones (Athens)"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.008_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hed.26024","article-title":"Clinical utility of 177 Lu-DOTATATE PRRT in somatostatin receptor-positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity","volume":"42","author":"Parghane","year":"2020","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.008_bib23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12885-021-08257-x","article-title":"Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review","volume":"21","author":"Maghsoomi","year":"2021","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.eprac.2023.12.008_bib24","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/sj.bjc.6601453","article-title":"The Ki67 index a prognostic marker in medullary thyroid carcinoma","volume":"89","author":"Tisell","year":"2003","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.008_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/PAS.0b013e31823d07f3","article-title":"Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting","volume":"36","author":"Korner","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.008_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.eprac.2023.12.008_bib27","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2967\/jnumed.112.105940","article-title":"Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma","volume":"53","author":"Verbeek","year":"2012","journal-title":"J\u00a0Nucl Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23007875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23007875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:15:54Z","timestamp":1761516954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23007875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1530891X23007875"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.12.008","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid Cancer","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. on behalf of the AACE. All rights reserved.","name":"copyright","label":"Copyright"}]}}